Haleon (HLN) FCF Payout Ratio (2021 - 2025)

Haleon's (HLN) quarterly FCF Payout Ratio came in at 4.32 in Q4 2025, down 137.57% on a QoQ basis from 1.82 in Q4 2023.

Haleon (HLN) FCF Payout Ratio (2021 - 2025) Analysis & Trends

Haleon (HLN) has 4 years of FCF Payout Ratio data on file, last reported at 4.32 in Q4 2025.

Quarterly FCF Payout Ratio changed N/A year-over-year to 4.32 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 10.46 (changed N/A YoY) and the FY2025 annual result came in at 0.26, down 4.75% from the prior year.
FCF Payout Ratio eased to 4.32 in Q4 2025, from 1.82 in the prior quarter.
In the past five years, FCF Payout Ratio ranged from a high of 0.1 in Q3 2022 to a low of 6.98 in Q4 2021.
A 4-year average of 2.59 and a median of 1.82 in 2023 frame the typical range for FCF Payout Ratio.
Annual changes were most pronounced in 2022 — FCF Payout Ratio jumped 101.37% — and 2023, when it tumbled 2003.67%.
Tracing HLN's FCF Payout Ratio over 4 years: stood at 6.98 in 2021, then jumped by 101.37% to 0.1 in 2022, then plunged by 2003.67% to 1.82 in 2023, then plunged by 137.57% to 4.32 in 2025.
The last three FCF Payout Ratio figures came in at 4.32 (Q4 2025), 1.82 (Q4 2023), and 0.1 (Q4 2022), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Cover (Qtr)
1	Haleon	43.94 Bn	42.97 Bn	-	-
2	Teva Pharmaceutical Industries	42.95 Bn	39.30 Bn	2.15 Bn	-
3	Zoetis	31.58 Bn	29.90 Bn	1.05 Bn	0.41
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn	-0.83
5	United Therapeutics	22.16 Bn	19.49 Bn	683.80 Mn	-
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn	0.42
7	Neurocrine Biosciences	15.53 Bn	15.14 Bn	935.80 Mn	-
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.11 Bn	9.95 Bn	-	-
10	Alkermes	8.12 Bn	7.46 Bn	397.90 Mn	-

Download Data